Member Info for jollygoodya

Seems the order book's been flipped in our favour. Once 60p holds it should push toward 70p resistance point.

But tide is turning, typical IMM. IMO will push up later. Will continue to hold for longterm gains. Imm in a strong position here.

https://www.thetimes.co.uk/article/drug-firms-are-racing-to-calm-the-cytokine-storm-l63w0hffc

On 30 March 2020, ImmuPharma announced that it had expanded its pipeline to include three new 'Anti-Infective' programs, one of which was in 'Antivirals'. Investigation of the application of the Ureka peptide technologies within this Antivirals program suggests the potential to create effective anti-fusion peptides with the goal to prevent virus entry into the host cells, which may lead to novel peptide based antiviral therapies. Further exploratory work continues on this program.

Best prevention would be to stop covid19 from attaching to host cells- Ureka and Lupuzor to control immune reaction looks like a strong platform for IMM. Ignore the speculator noise..

Negative posters/weakholders gone:)

A lot of people wanting to buy in cheaper. If you were invested you would not be negative. Remember some of these posters know how to play the market and sentiments and will want in cheaper. You dont get a giant like Avion to sign licence agreements without merit, yet people here know better than Avion, I guess lol!!!

Possibly but I would have thought they would do so at a higher price. However spike this is not. Expecting a sustained rise here.

100% agree Andle. Just need patience here and one will be rewarded. Imo we'ee only at the start of this new journey. Dont forget we're dual listed on the Euronext growth exchange...Bod are managing this carefully.

Andle, me thinks that maybe the case. Sp will take care of itself. This is way undervalued solely on the Avion lupus deal.

Great reminder post Boardsofuk, based solely on the Avion deal on lupis treatment we should surpass £1 easily once Avion complete the trial. Add Covid19, which sadly WHO say is here to stay for a long while then the value goes up exponentially. Bear in mind we have sole rights to Lupus treatement outside of the Avion US only deal. This company has the potential to be massive imo.

Off load is depressing the share price. Otherwise this is in a strong position and should have been easily at £1 plus. A lot of positive information about the treatment. Nebuliser at home would be priceless.

https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/

Strong rise here on further covid19 update. We have the right product under this environment.

On covid19 treatment gives good indicator of BoD intention to retain listing imo. If your were going to continue to delist, would you bother to delist? Has anyone even received voting circulars on plans?. Unlikely to happen now imo.

Longway to go here. Patent applied. Direct to source treatment, low risk. Combat body immune system overload due to covid19 hence big chance to reduce deaths. Sub £1 is peanuts here.

Yup, agree sam. Tils is here for the longhaul now.

Stocks imagine the worldwide potential. When the restrictions are lifted inhaler treatment will become even more invaluable. Sad to say that covid19 will be one of a line of viruses as can be seen with the sars chain. So imperative to have a delivery system that can combat variations. Very horrible scenario.

Via inhaler/nebulizer directly to the lungs will be a game changer as it can be safely undertaken at home once prescirbed. Reduce a lot of stress on NHS and family trauma. Massive potential here imo.

Agree this will be multiples of today. Not a one trick pony either.

Holding onto all my tickets. Big sales RNS cannot be far off.